Methadone Hydrochloride Concentrate
NDC Package 17856-0392-9

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Methadone Hydrochloride concentrates is 1.For detoxification treatment of opioid addiction (heroin or other morphine-like drugs). This formulation utilizes a concentrate delivery system. Marketed by Atlantic Biologicals Corp., this product is identified by NDC 17856-0392 and is authorized under FDA application ANDA040180.

Identification & Billing

NDC Package Code
17856-0392-9
Package Description
1 SYRINGE in 1 BAG / 2.5 mL in 1 SYRINGE
Product Code
17856-0392
11-Digit Billing Format
17856039209
RxNorm Crosswalk
  • RxCUI: 991147 - methadone HCl 10 MG in 1 mL Concentrate for Oral Solution
  • RxCUI: 991147 - methadone hydrochloride 10 MG/ML Oral Solution
  • RxCUI: 991147 - methadone hydrochloride 10 MG per 1 ML Oral Solution
  • RxCUI: 991147 - methadone hydrochloride 5 MG per 0.5 ML Oral Solution

Clinical Specifications

Proprietary Name
Methadone Hydrochloride
Non-Proprietary Name
Methadone Hydrochloride
Substance Name
Methadone Hydrochloride
Dosage Form
Concentrate - A liquid preparation of increased strength and reduced volume which is usually diluted prior to administration.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
METHADONE HYDROCHLORIDE 10 mg/mL
Pharmacologic Class
Usage Information
1.For detoxification treatment of opioid addiction (heroin or other morphine-like drugs). 2.For maintenance treatment of opioid addiction (heroin or other morphine-like drugs), in conjunction with appropriate social and medical services. Limitations of UseMethadone products used for the treatment of opioid addiction in detoxification or maintenance programs are subject to the conditions for distribution and use required under 21 CFR, Title 42, Sec 8 (see DOSAGE AND ADMINISTRATION).
DEA Schedule
Schedule II (CII) Substances

Regulatory & Marketing

Labeler Name
Atlantic Biologicals Corp.
Product Type
Human Prescription Drug
FDA Application #
ANDA040180
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-14-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (17856-0392). Click a package code to view its specific billing and regulatory data.

17856-0392-1
60 SYRINGE in 1 BOX, UNIT-DOSE / .5 mL in 1 SYRINGE
17856-0392-3
72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE / 2.5 mL in 1 CUP, UNIT-DOSE (17856-0392-4)
17856-0392-6
1 SYRINGE in 1 BAG / .5 mL in 1 SYRINGE
17856-0392-7
5 BOX, UNIT-DOSE in 1 SYRINGE / 60 SYRINGE in 1 BOX, UNIT-DOSE (17856-0392-2) / 1 mL in 1 SYRINGE (17856-0392-5)
17856-0392-8
1 SYRINGE in 1 BAG / 1 mL in 1 SYRINGE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 17856-0392-9 identifies a specific commercial package of 1 syringe in 1 bag / 2.5 ml in 1 syringe of Methadone Hydrochloride, a human prescription drug labeled by Atlantic Biologicals Corp.. This concentrate is formulated for oral use and contains methadone hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Atlantic Biologicals Corp. on May 14, 2019. The current certification is valid through December 31, 2026.

How is this Atlantic Biologicals Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 17856039209. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
17856-0392-9
11-Digit CMS (5-4-2)
17856-0392-09

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.